Guggenheim Capital’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $229K | Sell |
35,752
-2,044
| -5% | -$13.1K | ﹤0.01% | 1466 |
|
|
2025
Q1 | $134K | Buy |
37,796
+1,928
| +5% | +$6.83K | ﹤0.01% | 1581 |
|
|
2024
Q4 | $136K | Buy |
35,868
+20,470
| +133% | +$77.4K | ﹤0.01% | 1637 |
|
|
2024
Q3 | $49.9K | Sell |
15,398
-50
| -0.3% | -$162 | ﹤0.01% | 1846 |
|
|
2024
Q2 | $29.4K | Sell |
15,448
-890
| -5% | -$1.69K | ﹤0.01% | 1852 |
|
|
2024
Q1 | $46.4K | Buy |
16,338
+1,392
| +9% | +$3.95K | ﹤0.01% | 1860 |
|
|
2023
Q4 | $220K | Buy |
+14,946
| New | +$220K | ﹤0.01% | 1779 |
|